Hematology NewsVIDEO: ASH highlights five Choosing Wisely initiativesDecember 8, 2015Bleeding DisordersThrombosis
Hematology TimesIbrutinib ‘treatment of choice’ in rel/ref MCLDecember 8, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesRBC storage duration doesn’t affect outcomes in kidsDecember 8, 2015AnemiaBlood BankingPediatrics
Hematology TimesALL patients over-report their 6MP compliance, researchers sayDecember 8, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology NewsVIDEO: Top-line results from Tourmaline in multiple myeloma, plus ongoing trials and treatment selectionDecember 7, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsASH: Rituximab add-on therapy ‘new standard’ in BCP-ALLDecember 7, 2015ALLLeukemia, Myelodysplasia, Transplantation
Oncology PracticeTreatment delay linked with worse outcome for head and neck cancerDecember 7, 2015Head & Neck/Thyroid Cancers
Oncology PracticeADT linked to increased risk of Alzheimer’s diseaseDecember 7, 2015Genitourinary Cancer
Hematology NewsVIDEO: Novel GBT440 improves blood parameters in sickle cell diseaseDecember 7, 2015AnemiaPediatrics
Hematology NewsASH: Daratumumab and len/dex produce high response rates in refractory myelomaDecember 7, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsASH: All-oral regimen extends multiple myeloma PFSDecember 7, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsASH: First-line ibrutinib beats standard chemo for CLL/SLL in older patientsDecember 7, 2015CLLLymphoma & Plasma Cell Disorders
Hematology NewsVIDEO: Midostaurin hits mark in FLT3-mutated AMLDecember 7, 2015AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsVIDEO: Targeted agent, len/dex combo perform ‘impressively’ in advanced multiple myelomaDecember 7, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
